Korean J Med.  2004 Nov;67(Suppl 3):S814-S820.

Changes in VWF-cleaving Metalloprotease (ADAMTS 13) activity in the thrombotic microangiopathy after kidney tranplantation

• Lee YG
• Kim KH
• Cheon SC
• Hwang IJ
• Yang DH
• Oh D
• Kim KS

Abstract

The thrombotic microangiopathy associated with cyclosporine A after kidney transplantation is a detrimental complication that could lead to the loss of transplanted kidney. Although the pathogenesis is still unclear, the decrease in the activity of von Willebrand Factor (VWF)-cleaving metalloprotease that cleaves unusually large von-Willebrand factor (UL-VWF), such as disintegrin-like metalloprotease with thrombospondin type 1 repeats (ADAMTS) 13, and the inhibitory factors of ADAMTS 13 are reported. Therefore, we measured the activity of ADAMTS 13 and the inhibitory factors in a patient with thrombotic microangiopathy after kidney transplantation. A 28 year-old female patient with hemolytic anemia, thrombocytopenia and impaired renal function after the kidney transplantation was diagnosed as thrombotic microangiopathy after renal biopsy. The activity of ADAMTS 13 during the acute stage of thrombotic microangiopathy was reduced to 12%, but when the renal function returned to normal, ADAMTS 13 level returned to 100%. However, the autoantibody of ADAMTS 13 was not detected. The results from this study suggest that the pathogenesis of thrombotic microangiopathy associated with cyclosporine A after the kidney transplantation could be associated with the decrease in the activity of ADAMTS 13.

Keyword

Cyclosporine; Von Willebrand factor-cleaving metalloprotease; Thrombotic microangiopathy

MeSH Terms

Adult
Anemia, Hemolytic
Biopsy
Cyclosporine
Female
Humans
Kidney Transplantation
Kidney*
Thrombocytopenia
Thrombospondins
Thrombotic Microangiopathies*
von Willebrand Factor
Cyclosporine
Thrombospondins
von Willebrand Factor